Skip to main content
Premium Trial:

Request an Annual Quote

Eragen Signs up Aventis for Software License Renewal, Services

NEW YORK, July 15 -  EraGen Biosciences has signed up  Aventis for contract services and a renewal of a licensing agreement for the company's genomic-based software analysis system, EraGen said today.

 

Under the agreement,  Aventis will be able to access EraGen's technical support group for drug discovery using EraGen's Master Catalog software.

 

Master Catalog uses the evolutionary characteristics of 130 genomes, as well as Pathogenome, a proprietary database, for in silico prediction of proteins that are potential drug targets.

 

Eragen is based in Madison, Wis.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.